Benzoic acid,4-[3-[2-[2-[([1,1'-biphenyl]-2-ylsulfonyl)amino]ethyl]-5-chloro-1-(diphenylmethyl)-1H-indol-3-yl]propyl]-
CAS No. 540524-92-3
Pembrolizumab 1426814-54-1